The latest immunotherapy news and developments
Failed clinical trial leads to scientific breakthrough
It’s not often that a failed clinical trial leads to a scientific breakthrough. When patients…
Browsing: Immunotherapy
Gut microbiome may alter response to cancer therapy
Since ancient times, our gut microbiome, home to a vast number of bacteria, viruses, fungi,…
Researchers shed light on why a certain plant virus is so powerful at fighting cancer
A plant virus that infects legumes, called cowpea mosaic virus, has a special power that…
Combination immunotherapy improves outcomes for patients with non-small cell lung cancer
The phase 2 clinical trial of a multi-centre study known as the COAST clinical trial…
Predicting response to adoptive cell therapies in cancer
Recent advances in immunotherapy open the door to new approaches in cancer treatments. Patient variability…
Illumination of immune checkpoint LAG3 ‘black box’ could yield new cancer therapies
Fighting cancer and chronic disease is tiring work for the immune system. When T cells…
Particles released by red blood cells are effective carriers for anti-cancer immunotherapy
In the fight against cancer, the development of efficacious drugs is only half the battle;…
Study reveals male sex hormones are new targets for cancer immunotherapy
Patients with cancers stemming from non-reproductive organs, such as bladder and liver cancer, have striking…
Spatial maps of melanoma
Melanoma is a somewhat unusual cancer – one that blooms before our very eyes, often…
Epigenetic regulator plays a role in drug resistance in some lung cancer patients
Doctors typically treat people with non small cell lung cancer, a prevalent and typically incurable…